April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Silencing P2Y2 Receptors Reduce Intraocular Pressure
Author Affiliations & Notes
  • M. Perez de Lara
    Biochemistry and molecular biology, Escuela de Optica UCM, Madrid, Spain
  • A. Crooke
    Biochemistry and molecular biology, Escuela de Optica UCM, Madrid, Spain
  • C. Santano
    Biochemistry and molecular biology, Escuela de Optica UCM, Madrid, Spain
  • J. Pintor
    Biochemistry and molecular biology, Escuela de Optica UCM, Madrid, Spain
  • Footnotes
    Commercial Relationships  M. Perez de Lara, None; A. Crooke, None; C. Santano, None; J. Pintor, None.
  • Footnotes
    Support  RETICS RD07/0062/0004 and NEUROTRANS CM S-SAL-0253-2006
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1480. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Perez de Lara, A. Crooke, C. Santano, J. Pintor; Silencing P2Y2 Receptors Reduce Intraocular Pressure. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1480.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To silence the expression of P2Y2 receptors in New Zealand white rabbits and to check the effect this process produce on intraocular pressure (IOP).

Methods: : The rabbit P2Y2 receptor was cloned and according to its sequence siRNA were designed to silence the expression of this protein. Male New Zealand rabbits were used for the experiment. The siRNAs were topically applied in one eye, the contralateral receiving the same volume of saline. Each of the treated eyes received an amount of 250 µg of the siRNA dissolved in 40 µL of 0.9 % NaCl. IOP was measured with a TONOVET tonometer, along ten days and, afterwards, animals were killed and both eyes were collected for immunohystochemical studies.

Results: : The application of the siRNA against the P2Y2 receptor produced a marked reduction of intraocular pressure which was measurable 24 hours after the application of the siRNA. The maximal reduction in IOP was 52 ± 3.2 % and this hipotensive effect remained for at least five days, after which the pressure values returned towards normal (initial) IOP values. The mean of reduction in IOP was roughly 40 % during the time the hypotensive effect was measurable. The immunohystochemical analysis by means of P2Y2 receptor antibodies demonstrated a reduction of 85 % in the labelling of the mentioned receptor in the cilliary processes, this result being consistent with the reduction in IOP observed.

Conclusions: : The application of a siRNA that silence the P2Y2 receptor confirm the hypertensive role of this nucleotide in the control of IOP, that when silenced reduce concomitantly IOP to values which suggest its possible use for the treatment of ocular hypertension and glaucoma.

Keywords: RNAi • ciliary body • intraocular pressure 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.